T. Rowe Price Associates
GNMX

T. Rowe Price Associates’s Aevi Genomic Medicine Inc GNMX Stock Holding History

T. Rowe Price Associates’s Portfolio GNMX Stock Details GNMX Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
2018
Q2 		$307K Sell
2018
Q1 		$2.3M Buy
2017
Q1 		– Sell
2016
Q4 		$3.94M Sell
2016
Q3 		$4.25M Buy
2016
Q2 		$4.22M Sell
2016
Q1 		$3.37M Hold
2015
Q4 		$4.61M Buy